Page last updated: 2024-12-06
allyl chloroformate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 18052 |
| SCHEMBL ID | 37486 |
| MeSH ID | M0124557 |
Synonyms (53)
| Synonym |
|---|
| allylester kyseliny chlormravenci [czech] |
| un1722 |
| einecs 220-916-6 |
| chloroformic acid allyl ester |
| allyl chloroformate |
| 2-propenyl chloroformate |
| allyl chlorocarbonate |
| carbonochloridic acid, 2-propenyl ester |
| brn 0773915 |
| formic acid, chloro-, allyl ester |
| hsdb 621 |
| allyl chloroformate, 97% |
| prop-2-enyl chloroformate |
| inchi=1/c4h5clo2/c1-2-3-7-4(5)6/h2h,1,3h2 |
| caewjexpfknbql-uhfffaoysa- |
| prop-2-enyl carbonochloridate |
| STK802356 |
| prop-2-en-1-yl carbonochloridate |
| AKOS000121050 |
| allylchloroformate |
| allylester kyseliny chlormravenci |
| carbonochloridic acid, 2-propen-1-yl ester |
| allyl chloroformate [un1722] [poison] |
| unii-7672car559 |
| 7672car559 , |
| 2937-50-0 |
| A1268 |
| BBL011109 |
| FT-0622020 |
| allyl carbonochloridate |
| allyloxycarbonyl chloride |
| allyl chloridocarbonate |
| 2-propenyl chloroformate [hsdb] |
| 2-propen-1-yl chloroformate |
| ally chloroformate,>/= 98.5 % |
| SCHEMBL37486 |
| DTXSID2051972 |
| allylchoroformate |
| allyl chlorformate |
| aliylchloroformate |
| alloc-cl |
| un 1722 |
| allyl chloridocarbonate # |
| mfcd00000648 |
| allychloroformate |
| 560088-71-3 |
| FS-4334 |
| AMY3928 |
| Q27266461 |
| D87847 |
| ally chloroformate |
| EN300-21727 |
| chloro(prop-2-en-1-yloxy)methanone |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 35.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.60) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||